A meta-analysis of more than 1000 CRC patients receiving oxaliplatin found a single significant association of the ERCC1 rs11615 C allele with a higher risk of having haematological toxicity in Asian populations (HR = 1.97, p < 0.05) [100]. This evidence concerns the gene ERCC1 and colorectal carcinoma.